Proprietary drugs have a limited patent life and each year dozens of big drugs lose patent protection. As a result, generic competition kicks in for these drugs, their prices drop precipitously and the originating companies lose billions of dollars in revenues. But he fails to note the resulting societal impact that the loss of exclusivity for these erectile dysfunction (ED) drugs will have. Once generic competition occurs for a brand name drug, companies generally will stop direct-to-consumer advertising (DTC) for its medication. However, the impact on society for the loss of erectile dysfunction TV ads is unappreciated.

Source: Forbes February 24, 2017 12:59 UTC